Skip to main content
Home

Main navigation

  • About Us
    • Leadership Team
    • Our Experts
    • Client Testimonials
    • Alliances and Memberships
  • Services
    • Translational Medicine
    • Clinical Development and Operations
    • Regulatory and Peri-registration Activities
    • Rare Diseases & Advanced Therapeutics
    • Portfolio Management and Commercial Strategy
    • Drug Safety, Pharmacovigilance and Risk Management
    • Medical Affairs
  • Therapeutic Experience
    • Infectious Diseases
    • Oncology
    • Internal Medicine
    • Respiratory
    • CNS & Pain
  • Resources
    • News and Articles
    • Brochures
    • Webinars
    • Newsletters
    • Congresses & Events
    • Social Commitments
  • Careers
    • ATMP-Experienced Pharmaceutical Physician
    • Experienced Pharmaceutical Physicians
    • Clinical Project & Program Manager
    • Commercial Strategy & Portfolio Management
    • Neurology/CNS-Experienced Pharmaceutical Physician
    • Proposals Manager
    • Senior Clinical Project & Program Manager
  • Contact Us

Main navigation

  • About Us
    • Leadership Team
    • Our Experts
    • Client Testimonials
    • Alliances and Memberships
  • Services
  • Therapeutic Experience
  • Resources
    • News and Articles
    • Brochures
    • Webinars
    • Newsletters
    • Congresses & Events
    • Social Commitments
  • Careers
  • Contact Us

Pagination

  • Next page ››
tranScrip's Cocktail & Canapé Reception
Pancreatic cancer is a deadly disease with very few new treatments in the past 30 years
tranScrip further strengthen their translation development team
tranScrip's moderated patient session gets top ranking at Future Health Basel!
Carol Burley awarded an Honorary Fellowship of the Institute of Clinical Research (HonFICR) for her services as a member of the Institute’s Board of Directors
Faecal transplants show promise in boosting the efficacy of immunotherapy drugs
tranScrip welcomes Lisa Pearce Collins as Partner
Pharma firms leading the value-based care model must become patient-centric
Can a National Pain Strategy address the dual healthcare crises of chronic pain and prescription opioids?
MHRA Drug Safety Update for the use of fluoroquinolone antibiotics due to adverse side effects

Pagination

  • Next page ››
Footer menu
  • Legal
  • Sitemap

Information message

Newsroom Sign Up

Information message

Stay up to date with the latest news and views from tranScrip

+44 (0)118 963 7846

info@transcrip-partners.com

220 Wharfedale Road, Wokingham, RG41 5TP UK